Steve Smith Supporting Documents

The following documents were obtained by Steve Smith through the Canadian Access to Information Act:.
The text of the first three are on this page.
The images of the originals are from faxes and are 30k gifs.
Some signatures were blanked out.

Clinical Record from Penetanguishene

Original Docement Image

Request For Compressed Encounter Therapy

Original Document Image

Letter Requesting LSD Supply
Articles in the Canadian Psychiatric Association Journal by Dr. Elliott T. Barker

First Page Images:

LSD in a Coercive Milieu Therapy Program
The Total Encounter Capsule
Defence Disrupting Therapy

Article form Toronto Globe & Mail on Matt Lamb

Original Document Image

DEPARTMENT OF HEALTH FOR ONTARIO

MENTAL HEALTH BRANCH

Clinical Record

OH PENETANGUISHENE

NAME SMITH, Steven

PAGE

CASE No. 2094N

HOSPITAL INSURANCE CERTIFICATE No.

April 29, 1968. (W. Elrick, Surgery Attendant - jm.)

Given Gravol 100 mgs. 1.M. at 8:00 a.m. This patient to have extra juice today only, orders of Dr. MacVittle. Given physical examination. Blood taken for routine blood count and liver function test by Dr. MacVittle. [initialed]

May 7, 1968. (W. Elrick, Surgery Attendant - jm.)

Given Scopolomine grs. 1/75th intravenously at 9:30 a.m. and 10:00 a.m. [initialed]

May 9, 1968. (W. Elrick, Surgery Attendant - jm.)

Given Dexidrene Spansules 30 mgs. caps 2 at h.s. [initialed]

May 10, 1968. (W. Elrick, Surgery Attendant - jm.)

Given Dexidrene Spansules 15 mgs. caps 2 at h.s. [initialed]

April 28, 1968. Excerpt from Daily Ward Report - jm.)

Had what appeared to be a weak spell and fell flat to the floor, striking his face and causing a nose bleed. Attended to by Dr. Mackay. During the afternoon he complained of having a headache and feeling nauseated and was observed vomiting after supper. T 98, P 90, R 20. Patient rested quietly during the evening and appeared to be sleeping all night. [initialed]

May 14, 1968. (W. Elrick, Surgery Attendant - jm.)

Given Methidrene 30 mgs. I.M. at 1:30 p.m. [initialed]

May 16, 1968. (W. Elrick, Surgery Attendant - jm.)

Given Scopolomine grs. 1/75th per hype at 12:45 and 1:45 p.m. Given Methidrene 30 mgs. I.M. at 2:45 p.m. [initialed]

May 17, 1968. (W. Elrick, Surgery Attendant - jm.)

Given Hyacine Hydrobromide grs. 1/75th per hypo at 10:45 a.m. and 12:15 p.m. and 2:45 p.m. Given Prostigmine tabs 2 at 1:00 a.m. Given Methidrene 15 mgs. I.M. at 1:15 p.m. [initialed]

May 19, 1968. (W. Elrick, Surgery Attendant - jm.)

Given Dexidrene 30 mgs. I.M. at 1:00 p.m. [initialed]

May 22, 1968. (W. Elrick, Surgery Attendant - jm.)

Given Methidrene 30 mgs. I.M. at 1:00 p.m. [initialed]

May 22, 1968. (W. Elrick, Surgery Attendant - jm.)

Received Dexamyl Spansules #2, caps 2 at 9:00 p.m. [initialed]

May 24, 1968. (W. Elrick, Surgery Attendant - jm.)

Given Methidrene 30 mgs. intravenously by Dr. Barker at 12:45 p.m. [initialed]

May 25, 1968. (W. Elrick, Surgery Attendant - jm.)

Given Dexidrene Spansules caps 2, 30 mgs, at 10:15 p.m. [initialed]

May 26, 1968. (W. Elrick, Surgery Attendant - jm.)

Given Dexidrene Spansules caps 2, 30 mgs., at 10:20 p.m. [initialed]

Signature whited out

Contents

27th December, 1967

REQUEST FOR COMPRESSED ENCOUNTER THERAPY

Realizing that my chances of recovery and release are improved considerably by intensive treatment, I request admission to the Compressed Encounter Therapy Unit on "F" ward. I am ready to meet the conditions of treatment specified below:

1. Commitment to an indefinite period of group interaction under conditions of the most stringent security.
   
2. Agreement to take such medications as the ward psychiatrist may judge likely to hasten or otherwise assist in my treatment. Such medications might include scopolamine, methedrine, mescalin, psilocybin, sodium amytal, dexedrine, etc.
   
3. Readiness to discourage contact with relatives and friends either by mail or visit for the duration of my treatment in the Compressed Encounter Therapy Unit, in the awareness that I may use this as a defence, to slow treatment; and willingness not to apply to the Review Board for release, knowing that this also may be a resort to avoid the encounters that constitute therapy.
   
4. Willingness to acknowledge that since the anxiety aroused by intensive treatment may distort my judgment in the matter, the opinion of my peers and the ward staff about my readiness for discharge from the Compressed Encounter Therapy Unit, is better and more relevant than my own, and should on all occasions hold more weight.
   
5. Commitment to the treatment of my fellow group members as the most effective means of help for myself, and consequent agreement to assume responsibility for their treatment and safety.

I HEREBY AGREE TO THE ABOVE CONDITIONS.

Steven Smith (signature of patient) May 3 (date)

Ken Smith (signature of witness) May 3 (date)

Contents

ONTARIO
Ministry of Health
Mental Health Center
705-549-7431
Penetanguishene
Ontario LOK IPO
   
June 19th, 1973
   
Mr. Russ Graham
Scientific Services
Health Protection,
Tunney Pasture,
Ottawa, Ontario
   
Dear Mr. Graham:

On February the 1st, 1967 Mr. Chapman approved a request for 20 milligrams of Lysergic Acid Dieghylamide (sic) for use at the Mental Health Center, Penetanguishene, Oak Ridge Division. [NAME BLACKED OUT] was the qualified investigator and the purpose of the LSD was for clinical research. Enclosed please find a xeroxed copy of the notice of approval of sale of Schedule H drugs. In September of 1972, we used up the last LSD and are in the process of presenting a paper which summarizes our use of this drug, and when this paper is finished we intend to send it to your Ministry for approval.

It is my intention at the present time to request a further 20 milligrams of LSD to the continued therapeutic use with the patients at the maximum security hospital in Penetang. We would wish to continue to use it as we have in the past, bound by the same conditions or others which might have subsequently emerged. At the present time it is our (sic) understanding that the Connaught Medical Research Laboratories in Willowdale are not dispensing this drug and would also wish to know which drug company has the authority to dispense LSD.

I hope this letter is clear in our request and we would be happy to share any information with you that you might deem helpful. We are also prepared to have a research committee set up. You will also find enclosed the rough draft of our application for purchase of Lysergic Acid Dieghylamide to the director of the Connaught Medical Research Laboratories in Willowdale. It is the intention that I would be the qualified investigator.

I await your reply. Thank you for your interest.

Yours truly,

Contents